Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APL510 for improving daytime sleep in permanent night-shift workers
ISRCTN15733268Phase 2Completed
- Sponsor
- Alliance Pharma
- Start
- Oct 2005
- Modality
- Small Molecules
01
Overview
Phase 2 trial of APL510, sponsored by Alliance Pharma. Started Oct 2005; status: completed.
02
Drugs
APL510
Beyond the preview
Go deeper on ISRCTN15733268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15733268.